180 related articles for article (PubMed ID: 31690815)
1. Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis.
Kemi N; Eskuri M; Kauppila JH
Sci Rep; 2019 Nov; 9(1):16018. PubMed ID: 31690815
[TBL] [Abstract][Full Text] [Related]
2. Tumour-stroma ratio and prognosis in gastric adenocarcinoma.
Kemi N; Eskuri M; Herva A; Leppänen J; Huhta H; Helminen O; Saarnio J; Karttunen TJ; Kauppila JH
Br J Cancer; 2018 Aug; 119(4):435-439. PubMed ID: 30057407
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract][Full Text] [Related]
4. Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer.
Liu L; Xu L; Wu D; Zhu Y; Li X; Xu C; Chen K; Lin Y; Lao J; Cai P; Li X; Luo Y; Li X; Huang J; Lin T; Zhong W
EBioMedicine; 2024 Jun; 104():105152. PubMed ID: 38728838
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis.
Jamel S; Markar SR; Malietzis G; Acharya A; Athanasiou T; Hanna GB
Gastric Cancer; 2018 Jan; 21(1):10-18. PubMed ID: 28779261
[TBL] [Abstract][Full Text] [Related]
6. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
7. Tumor-stroma ratio(TSR) as a potential novel predictor of prognosis in digestive system cancers: A meta-analysis.
Zhang R; Song W; Wang K; Zou S
Clin Chim Acta; 2017 Sep; 472():64-68. PubMed ID: 28729135
[TBL] [Abstract][Full Text] [Related]
8. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Stroma Ratio is an independent predictor for overall survival and disease free survival in gastric cancer patients.
Aurello P; Berardi G; Giulitti D; Palumbo A; Tierno SM; Nigri G; D'Angelo F; Pilozzi E; Ramacciato G
Surgeon; 2017 Dec; 15(6):329-335. PubMed ID: 28629870
[TBL] [Abstract][Full Text] [Related]
10. [Extended Pathohistological Criteria for Assessment of the Long-Term Prognosis of Gastric Cancer].
Dittmar Y; Rauchfuss F; Dondorf F; Ardelt M; Scheuerlein H; Settmacher U
Zentralbl Chir; 2016 Aug; 141(4):433-41. PubMed ID: 25723861
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Tumor-Stroma Ratio in Rectal Cancer: A Systematic Review and Meta-analysis.
Zhu Y; Jin Z; Qian Y; Shen Y; Wang Z
Front Oncol; 2021; 11():685570. PubMed ID: 34123856
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma.
Sada YH; Smaglo BG; Tan JC; Tran Cao HS; Musher BL; Massarweh NN
J Natl Compr Canc Netw; 2019 Feb; 17(2):161-168. PubMed ID: 30787129
[No Abstract] [Full Text] [Related]
13. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
15. Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis.
Yang Y; Yin X; Sheng L; Xu S; Dong L; Liu L
Sci Rep; 2015 Aug; 5():12850. PubMed ID: 26242393
[TBL] [Abstract][Full Text] [Related]
16. Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4.
el Aziz LM
Med Oncol; 2014 Dec; 31(12):311. PubMed ID: 25367855
[TBL] [Abstract][Full Text] [Related]
17. Prognostic differences in 8th edition TNM staging of esophagogastric adenocarcinoma after neoadjuvant treatment.
Sisic L; Blank S; Nienhüser H; Dorr S; Haag GM; Jäger D; Bruckner T; Müller-Stich BP; Ott K; Büchler MW; Ulrich A; Schmidt T
Eur J Surg Oncol; 2018 Oct; 44(10):1646-1656. PubMed ID: 30082176
[TBL] [Abstract][Full Text] [Related]
18. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
19. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.
Wu J; Liang C; Chen M; Su W
Oncotarget; 2016 Oct; 7(42):68954-68965. PubMed ID: 27661111
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis.
Xu WY; Yang XB; Wang WQ; Bai Y; Long JY; Lin JZ; Xiong JP; Zheng YC; He XD; Zhao HT; Sang XT
World J Gastroenterol; 2018 May; 24(19):2120-2129. PubMed ID: 29785080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
